Pol Arch Intern Med. 2018 Dec 21;128(12):739-745. doi: 10.20452/pamw.4352. Epub 2018 Oct 18.
INTRODUCTION During the last decade, aortic stenosis (AS) has emerged as one of the most significant concerns in cardiovascular diseases. OBJECTIVES We aimed to characterize AS patients on the basis of data derived from a local registry. PATIENTS AND METHODS We used data from the SILesian CARDiovascular (SILCARD) registry, which was developed under the agreement between the Silesian Centre for Heart Diseases in Zabrze and the Silesian branch of the Polish National Health Fund in Katowice to conduct a comprehensive analysis of patients with cardiovascular diseases in Silesian Voivodeship. RESULTS A total of 15 158 patients hospitalized with a diagnosis of AS between 2006 and 2016 were included (mean [SD] age, 69.87 [11.97] years; male patients, 7644 [50.43%]). Heart failure was reported in 4187 patients (27.62%), and coronary artery disease, in 6217 (41.01%). During the first hospitalization, aortic valve intervention was performed in 2137 patients (14.10%), and during a 12‑‑ month follow‑‑ up, in 3416 (25.32%). During the first hospitalization, percutaneous coronary intervention (PCI) was performed in 666 patients (4.39%), and coronary artery bypass grafting (CABG), in 1071 (6.71%). At 12‑‑ month follow‑‑ up, PCI was reported in 560 patients (4.15%), and CABG, in 560 (4.15%). Between 2006 and 2016, 30‑‑ day mortality was 4.35% (659 patients) and remained stable throughout the study (5.4% in 2005 vs 4.0% in 2016, P = 0.28). The 1‑‑ year mortality was 15.88% (2142 patients) and increased from 14.3% in 2006 to 16% in 2015 (P = 0.07). CONCLUSIONS The SILCARD registry has revealed an increase in the number of AS diagnoses. AS has become one of the most critical issues among cardiovascular diseases in Silesian Voivodeship.
在过去的十年中,主动脉瓣狭窄(AS)已成为心血管疾病中最严重的问题之一。
我们旨在根据当地注册中心的数据对 AS 患者进行特征描述。
我们使用了 SILesian CARDiovascular(SILCARD)注册中心的数据,该注册中心是在扎布热西里西亚心脏疾病中心与卡托维兹西里西亚分部的波兰国家卫生基金之间的协议下建立的,旨在对西里西亚省的心血管疾病患者进行全面分析。
共纳入 2006 年至 2016 年期间因诊断为 AS 而住院的 15158 例患者(平均[标准差]年龄 69.87[11.97]岁;男性患者 7644[50.43%])。4187 例(27.62%)患者报告存在心力衰竭,6217 例(41.01%)患者报告存在冠心病。首次住院时,2137 例(14.10%)患者接受了主动脉瓣介入治疗,12 个月随访时,3416 例(25.32%)患者接受了治疗。首次住院时,666 例(4.39%)患者接受了经皮冠状动脉介入治疗(PCI),1071 例(6.71%)患者接受了冠状动脉旁路移植术(CABG)。12 个月随访时,560 例(4.15%)患者接受了 PCI 治疗,560 例(4.15%)患者接受了 CABG 治疗。2006 年至 2016 年期间,30 天死亡率为 4.35%(659 例),整个研究期间保持稳定(2005 年为 5.4%,2016 年为 4.0%,P=0.28)。1 年死亡率为 15.88%(2142 例),从 2006 年的 14.3%上升至 2015 年的 16%(P=0.07)。
SILCARD 注册中心显示 AS 诊断数量有所增加。AS 已成为西里西亚省心血管疾病中最关键的问题之一。